Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421380 · ClinicalTrials.gov registry record · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
A NA study of Malignant Solid Tumors, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 109
- Enrollment target
- 2
- Study locations
NCT02421380 is a NA study of Malignant Solid Tumors that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 109 participants, below the 3,358-participant average among 3 other Malignant Solid Tumors trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02421380, a NA study of Malignant Solid Tumors, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to test a new approach to see if the test results can be reproduced each time the Magnetic resonance imaging (MRI) is done for an individual patient. The study will explore the use of an imaging agent called hyperpolarized \[1-13C\] pyruvate (HP) with MRI scans. (MRI) is a technique that takes pictures of the body's organs using a magnetic field and radiofrequency waves that cannot be felt. In order to accomplish the goal of the study the patient will have two hyperpolarized MRI scans to assess if scans can be reproduced. The hyperpolarized MRI scans will be compared with the pathological results of the surgery to see if the hyperpolarized MRI provides additional information regarding disease metabolism.
Conditions Studied
Interventions
- DRUG Hyperpolarized Pyruvate
Study Locations (2)
New Jersey
- Memorial Sloan Kettering Bergen (Consent only ) - Montvale
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2015-04 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02421380
The ClinicalTrials.gov registry entry for NCT02421380 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,358-participant average among 3 other Malignant Solid Tumors trials with a reported enrollment target (97% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which Hyperpolarized Pyruvate is the first listed.
NCT02421380 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT02421380 about?
NCT02421380 is a clinical study titled "Characterization of Hyperpolarized Pyruvate MRI Reproducibility". The purpose of the study is to test a new approach to see if the test results can be reproduced each time the Magnetic resonance imaging (MRI) is done for an individual patient. The study will explore the use of an imaging agent called hyperpolarized \[1-13C\] pyruvate (HP) with MRI scans. (MRI) is ...
What is the current status of trial NCT02421380?
This trial is currently recruiting. It is a NA study. The enrollment target is 109 participants. The study started on 2015-04. Estimated completion is 2026-04.
What conditions does trial NCT02421380 study?
This clinical trial studies the following conditions: Malignant Solid Tumors.
What interventions are being tested in trial NCT02421380?
The interventions under investigation include: Hyperpolarized Pyruvate (DRUG).
Who is sponsoring clinical trial NCT02421380?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02421380 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.